Hyperbaric Oxygen Therapy for Traumatic Brain Injury (TBI) in Concord, CA

Traumatic brain injury (TBI) is caused by a sudden external force — impact, blast wave, penetrating injury, or violent shaking — that damages brain tissue. In the United States, approximately 2.5 million emergency department visits are related to TBI each year, and an estimated 5.3 million Americans are currently living with a TBI-related disability. Motor vehicle accidents, falls, sports injuries (including football, soccer, hockey, and cycling), and combat blast exposure are the leading causes.

TBI is classified by severity: mild TBI (including concussion), characterized by brief or no loss of consciousness; moderate TBI, involving loss of consciousness of minutes to hours; and severe TBI, involving extended unconsciousness or amnesia. What is increasingly recognized, however, is that "mild" TBI is often not mild in its long-term consequences. Repetitive subconcussive impacts — common in contact sports — and even single moderate concussions can produce persistent post-concussive syndrome lasting months to years, with symptoms that profoundly affect quality of life and work capacity.

The underlying pathophysiology of persistent TBI symptoms involves multiple overlapping processes: primary mechanical injury to axons and neurons, followed by a secondary injury cascade involving neuroinflammation, mitochondrial dysfunction, cerebral blood flow disruption, and the accumulation of neurotoxic metabolites. It is these chronic, secondary processes that HBOT is uniquely equipped to address.

The key insight driving HBOT's application in TBI is the concept of the “penumbra” — the zone of metabolically impaired but structurally intact brain tissue surrounding the primary injury. These neurons are functionally silent (not producing output) because they lack sufficient oxygen and energy to fire, but they are not dead. Standard medicine largely treats this tissue as permanently lost. HBOT treats it as recoverable.

At 1.5 to 2.5 atmospheres of 100% oxygen, HBOT delivers dissolved oxygen concentrations high enough to penetrate into ischemic, hypoxic penumbral tissue. This oxygen reactivates the mitochondrial energy production these neurons require to resume function, reverses the synaptic dysfunction that blocks communication between regions, and suppresses the neuroinflammatory signaling that has been keeping these circuits in a state of chronic depression. Over a series of treatments, functional MRI and SPECT imaging studies have shown measurable increases in cerebral blood flow and neural activity in regions that were previously hypofunctional.

Critically, HBOT stimulates neuroplasticity — the brain's capacity to reorganize and form new connections — through increases in BDNF (brain-derived neurotrophic factor), VEGF, and growth hormone release. These factors promote new synaptic connections and axonal regrowth, supporting recovery that extends beyond the HBOT treatment period itself. Research by Dr. Shai Efrati and his team at Tel Aviv University, including studies published in PLOS ONE and Journal of Neurotrauma, has demonstrated significant cognitive improvements in chronic TBI patients (>3 years post-injury) treated with HBOT — establishing that recovery potential does not have a fixed deadline. At NorCal Hyperbarics, protocols are typically 40 to 60 sessions, tailored to injury severity and chronicity.